Pharmaceutical

Filter

Current filters:

None

Popular Filters

55 to 79 of 6951 results

Baxter exceeds own predictions in 2nd-quarter

Baxter exceeds own predictions in 2nd-quarter

17-07-2014

US drugmaker Baxter International reported strong growth across its global franchises in the second quarter…

Baxter InternationalFinancialFundamental analysisPharmaceuticalUSAValuation

US breakthrough designation in IPF for Boehringer’s nintedanib

US breakthrough designation in IPF for Boehringer’s nintedanib

17-07-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation for German family-owned…

Boehringer IngelheimnintedanibPharmaceuticalRegulationRespiratory and PulmonaryUSA

Attractions and challenges of Poland’s pharmaceutical market

Attractions and challenges of Poland’s pharmaceutical market

17-07-2014

Not only is Poland the largest pharmaceutical market in the Central & Eastern Europe region and the sixth…

HealthcareMarkets & MarketingPharmaceuticalPolandPricing

Abbott Labs 2nd-quarter revenues rise 1.9%

Abbott Labs 2nd-quarter revenues rise 1.9%

17-07-2014

US health care company Abbott Laboratories, which since its spin-out of its research-based prescription…

Abbott LaboratoriesFinancialPharmaceutical

Novartis 2nd-qtr sales and net profit up but miss analysts’ forecasts

Novartis 2nd-qtr sales and net profit up but miss analysts’ forecasts

17-07-2014

Switzerland’s Novartis – now the world’s largest pharmaceutical company by sales - this morning…

AlconFinancialNovartisPharmaceuticalSandoz

Pfizer’s BeneFIX reduces bleeding rates in Ph III study

Pfizer’s BeneFIX reduces bleeding rates in Ph III study

16-07-2014

US pharma giant Pfizer today released positive results of a Phase III study comparing a prophylaxis regimen…

BenefixHaemophiliaHematologyHemophilia BPfizerPharmaceuticalResearchSevere hemophilia BUSA

Bayer the latest in anticoagulant lawsuit action

Bayer the latest in anticoagulant lawsuit action

16-07-2014

German drug major Bayer is just one of the latest companies to be facing lawsuits over its anticoagulants,…

BayerBoehringer IngelheimHematologyHematologyLegalPharmaceuticalPradaxaRivaroxabanUSAWarfarin SodiumXarelto

Aptuit names Paul Overton executive vice president of business development and marketing

Aptuit names Paul Overton executive vice president of business development and marketing

16-07-2014

US-based drug development and discovery company Aptuit has appointed Paul Overton as executive vice president,…

AptuitBoardroomPharmaceuticalUSA

Breast cancer: DMP is largely consistent with guidelines, says IQWiG

Breast cancer: DMP is largely consistent with guidelines, says IQWiG

16-07-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has today published the results…

Breast cancerGermanyInstitute for Quality and Efficiency in Health CareOncologyPharmaceuticalRegulation

CellAct Pharma receives orphan drug designation in EU for cancer drug

CellAct Pharma receives orphan drug designation in EU for cancer drug

16-07-2014

The European Medicines Agency’s Committee for Orphan Medicinal Products has granted German cancer specialists…

CAP7.1CellAct PharmaEuropeGermanyHepatologyOncologyPharmaceuticalRegulationTreatment of biliary tract cancers

BTG on track in 2nd-qtr financials

BTG on track in 2nd-qtr financials

16-07-2014

UK-based specialist health care company BTG has announced its interim management statement for the period…

BTGFinancialPharmaceuticalUKVarithena

Packaging and delivery specialist West opens first plant in India

Packaging and delivery specialist West opens first plant in India

16-07-2014

US packaging and delivery company West has dedicated its manufacturing plant in the Sri City Special…

ChennaiIndiaPharmaceuticalProductionSri CityWest

LEO Pharma strikes global dermatology deal with KLOK Tech

LEO Pharma strikes global dermatology deal with KLOK Tech

16-07-2014

Danish dermatology specialist LEO Pharma and Canada’s KLOX Technologies, both privately-held companies,…

Acne vulgarisDermatologicalsGlobalKLOX TechnologiesLEO PharmaLicensingPharmaceutical

New products drive 2nd-qtr growth for Johnson & Johnson

New products drive 2nd-qtr growth for Johnson & Johnson

15-07-2014

Global health care products giant Johnson & Johnson, the first pharma to report second-quarter 2014 financial…

Business FinanceFinancialJohnson & JohnsonMonoclonal antibodiesPharmaceuticalPrednisoneUSA

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

15-07-2014

New Zealand Pharmaceutical Management Agency PHARMAC has awarded a tender to Netherlands-headquartered…

Antibiotics and Infectious diseasesFinancialHealthcareNew ZealandNorginePharmaceuticalXifaxan

moksha8 to commercialize BIAL’s eslicarbazepine in Brazil and Mexico

moksha8 to commercialize BIAL’s eslicarbazepine in Brazil and Mexico

15-07-2014

Portuguese drugmaker BIAL and Brazil-based moksha8 have entered an exclusive license for the commercialization…

BIALBrazileslicarbazepineExaliefLicensingMexicoMoksha8NeurologicalPharmaceuticalPortugalZebinix

55 to 79 of 6951 results

Back to top